Viagen Equine has led the world in the commercialization of somatic cell nuclear
transfer for many different species. We have earned the trust of clients around the
world, including the San Diego Zoo, United States Fish and Wildlife, and thousands
of horse and pet clients.
Our exclusive licensing of the Roslin Institute SCNT patent portfolio and our
ability to effectively commercialize new technology have positioned Viagen Equine as
an undisputed world leader in advanced reproduction.
We have branched out into the ICSI field in response to growing demand from our
clients and partners, who have encouraged Viagen Equine to apply our proprietary
techniques to this growing and important field of advanced reproduction.